Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 778 results
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Liu J, Deng Y, Li Q, Dey AK, Moore JP, Lu M.  2010.  Role of a putative gp41 dimerization domain in human immunodeficiency virus type 1 membrane fusion.. J Virol. 84(1):201-9.
Mao N, Kojic M, Holloman WK.  2009.  Role of Blm and collaborating factors in recombination and survival following replication stress in Ustilago maydis.. DNA Repair (Amst). 8(6):752-9.
Liu J, Xiang Z, Ma X.  2004.  Role of IFN regulatory factor-1 and IL-12 in immunological resistance to pathogenesis of N-methyl-N-nitrosourea-induced T lymphoma.. J Immunol. 173(2):1184-93.
Yamamoto S, Ma X.  2009.  Role of Nod2 in the development of Crohn's disease.. Microbes Infect. 11(12):912-8.
Berens C, Schnappinger D, Hillen W.  1997.  The role of the variable region in Tet repressor for inducibility by tetracycline.. J Biol Chem. 272(11):6936-42.
Blumenthal A, Kobayashi T, Pierini LM, Banaei N, Ernst JD, Miyake K, Ehrt S.  2009.  RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins.. Cell Host Microbe. 5(1):35-46.
Ehrt S, Ornston LN, Hillen W.  1994.  RpoN (sigma 54) is required for conversion of phenol to catechol in Acinetobacter calcoaceticus.. J Bacteriol. 176(12):3493-9.
S
Mazloum N, Holloman WK.  2009.  Second-end capture in DNA double-strand break repair promoted by Brh2 protein of Ustilago maydis.. Mol Cell. 33(2):160-70.
Bryk R, Gold B, Venugopal A, Singh J, Samy R, Pupek K, Cao H, Popescu C, Gurney M, Hotha S et al..  2008.  Selective killing of nonreplicating mycobacteria.. Cell Host Microbe. 3(3):137-45.
Zhan W, Hsu H-C, Morgan T, Ouellette T, Burns-Huang K, Hara R, Wright AG, Imaeda T, Okamoto R, Sato K et al..  2019.  Selective Phenylimidazole-Based Inhibitors of the Mycobacterium tuberculosis Proteasome.. J Med Chem. 62(20):9246-9253.
Stein SC, Falck-Pedersen E.  2012.  Sensing adenovirus infection: activation of interferon regulatory factor 3 in RAW 264.7 cells.. J Virol. 86(8):4527-37.
Ma X.  2018.  Sensing danger through a "finger".. J Exp Med. 215(12):2969-2971.
Nociari M, Ocheretina O, Schoggins JW, Falck-Pedersen E.  2007.  Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator.. J Virol. 81(8):4145-57.
Hu X, Herrero C, Li W-P, Antoniv TT, Falck-Pedersen E, Koch AE, Woods JM, G Haines K, Ivashkiv LB.  2002.  Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation.. Nat Immunol. 3(9):859-66.
Kang X, Kim H-J, Ramirez M, Salameh S, Ma X.  2010.  The septic shock-associated IL-10 -1082 A > G polymorphism mediates allele-specific transcription via poly(ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells.. J Immunol. 184(7):3718-24.
Prescott J, Falck-Pedersen E.  1994.  Sequence elements upstream of the 3' cleavage site confer substrate strength to the adenovirus L1 and L3 polyadenylation sites.. Mol Cell Biol. 14(7):4682-93.
Prescott JC, Liu L, Falck-Pedersen E.  1997.  Sequence-mediated regulation of adenovirus gene expression by repression of mRNA accumulation.. Mol Cell Biol. 17(4):2207-16.
Xiang Z, Hu XL, Flint J, Riethman HC.  1999.  A sequence-ready map of the human chromosome 17p telomere.. Genomics. 58(2):207-10.
Xiang Z, Morse E, Hu XL, Flint J, Chi HC, Grady DL, Moyzis RK, Riethman HC.  2001.  A sequence-ready map of the human chromosome 1q telomere.. Genomics. 72(1):105-7.
DeZazzo JD, Falck-Pedersen E, Imperiale MJ.  1991.  Sequences regulating temporal poly(A) site switching in the adenovirus major late transcription unit.. Mol Cell Biol. 11(12):5977-84.
Lue NF.  1999.  Sequence-specific and conformation-dependent binding of yeast telomerase RNA to single-stranded telomeric DNA.. Nucleic Acids Res. 27(12):2560-7.
Hashimoto M, Barany F, Xu F, Soper SA.  2007.  Serial processing of biological reactions using flow-through microfluidic devices: coupled PCR/LDR for the detection of low-abundant DNA point mutations.. Analyst. 132(9):913-21.
Mastrangeli A, Harvey BG, Yao J, Wolff G, Kovesdi I, Crystal RG, Falck-Pedersen E.  1996.  "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.. Hum Gene Ther. 7(1):79-87.
Schoggins JW, Falck-Pedersen E.  2009.  Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.. Virology. 395(1):10-20.
Deitsch KW, Moxon ER, Wellems TE.  1997.  Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections.. Microbiol Mol Biol Rev. 61(3):281-93.